222 related articles for article (PubMed ID: 27185459)
1. A cross sectional study of two independent cohorts identifies serum biomarkers for facioscapulohumeral muscular dystrophy (FSHD).
Petek LM; Rickard AM; Budech C; Poliachik SL; Shaw D; Ferguson MR; Tawil R; Friedman SD; Miller DG
Neuromuscul Disord; 2016 Jul; 26(7):405-13. PubMed ID: 27185459
[TBL] [Abstract][Full Text] [Related]
2. Identification of Serum Interleukin 6 Levels as a Disease Severity Biomarker in Facioscapulohumeral Muscular Dystrophy.
Gros M; Nunes AM; Daoudlarian D; Pini J; Martinuzzi E; Barbosa S; Ramirez M; Puma A; Villa L; Cavalli M; Grecu N; Garcia J; Siciliano G; Solé G; Juntas-Morales R; Jones PL; Jones T; Glaichenhaus N; Sacconi S
J Neuromuscul Dis; 2022; 9(1):83-93. PubMed ID: 34459413
[TBL] [Abstract][Full Text] [Related]
3. Proteomics of Muscle Microdialysates Identifies Potential Circulating Biomarkers in Facioscapulohumeral Muscular Dystrophy.
Corasolla Carregari V; Monforte M; Di Maio G; Pieroni L; Urbani A; Ricci E; Tasca G
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396627
[TBL] [Abstract][Full Text] [Related]
4. A Targeted Approach for Evaluating DUX4-Regulated Proteins as Potential Serum Biomarkers for Facioscapulohumeral Muscular Dystrophy Using Immunoassay Proteomics.
Campbell AE; Arjomand J; King OD; Tawil R; Jagannathan S
J Neuromuscul Dis; 2023; 10(6):1031-1040. PubMed ID: 37899061
[TBL] [Abstract][Full Text] [Related]
5. Facioscapulohumeral dystrophy transcriptome signatures correlate with different stages of disease and are marked by different MRI biomarkers.
van den Heuvel A; Lassche S; Mul K; Greco A; San León Granado D; Heerschap A; Küsters B; Tapscott SJ; Voermans NC; van Engelen BGM; van der Maarel SM
Sci Rep; 2022 Jan; 12(1):1426. PubMed ID: 35082321
[TBL] [Abstract][Full Text] [Related]
6. Muscle pathology grade for facioscapulohumeral muscular dystrophy biopsies.
Statland JM; Shah B; Henderson D; Van Der Maarel S; Tapscott SJ; Tawil R
Muscle Nerve; 2015 Oct; 52(4):521-6. PubMed ID: 25704033
[TBL] [Abstract][Full Text] [Related]
7. The facioscapulohumeral muscular dystrophy - health index: Italian validation of a disease-specific measure of symptomatic burden.
Carraro E; Greco LC; Lizio A; Beretta M; Pozzi S; Casiraghi J; Becchiati S; Beshiri F; Frisoni MC; Iossa F; Heatwole C; Sansone V
Disabil Rehabil; 2024 May; 46(10):2130-2137. PubMed ID: 37194629
[TBL] [Abstract][Full Text] [Related]
8. Muscle ultrasound is a responsive biomarker in facioscapulohumeral dystrophy.
Goselink RJM; Schreuder THA; Mul K; Voermans NC; Erasmus CE; van Engelen BGM; van Alfen N
Neurology; 2020 Apr; 94(14):e1488-e1494. PubMed ID: 32132178
[TBL] [Abstract][Full Text] [Related]
9. MRI as outcome measure in facioscapulohumeral muscular dystrophy: 1-year follow-up of 45 patients.
Andersen G; Dahlqvist JR; Vissing CR; Heje K; Thomsen C; Vissing J
J Neurol; 2017 Mar; 264(3):438-447. PubMed ID: 28000006
[TBL] [Abstract][Full Text] [Related]
10. Establishing the role of muscle ultrasound as an imaging biomarker in facioscapulohumeral muscular dystrophy.
Vincenten SCC; Teeselink S; Voermans NC; van Engelen BGM; Mul K; van Alfen N
Neuromuscul Disord; 2023 Dec; 33(12):936-944. PubMed ID: 37968164
[TBL] [Abstract][Full Text] [Related]
11. Five-year follow-up study on quantitative muscle magnetic resonance imaging in facioscapulohumeral muscular dystrophy: The link to clinical outcome.
Vincenten SCC; Mul K; van As D; Jansen JJ; Heskamp L; Heerschap A; van Engelen BGM; Voermans NC
J Cachexia Sarcopenia Muscle; 2023 Aug; 14(4):1695-1706. PubMed ID: 37218549
[TBL] [Abstract][Full Text] [Related]
12. Muscle MRI of facioscapulohumeral dystrophy (FSHD): A growing demand and a promising approach.
Fatehi F; Salort-Campana E; Le Troter A; Bendahan D; Attarian S
Rev Neurol (Paris); 2016 Oct; 172(10):566-571. PubMed ID: 27663058
[TBL] [Abstract][Full Text] [Related]
13. Tracking muscle wasting and disease activity in facioscapulohumeral muscular dystrophy by qualitative longitudinal imaging.
Monforte M; Laschena F; Ottaviani P; Bagnato MR; Pichiecchio A; Tasca G; Ricci E
J Cachexia Sarcopenia Muscle; 2019 Dec; 10(6):1258-1265. PubMed ID: 31668022
[TBL] [Abstract][Full Text] [Related]
14. Three novel serum biomarkers, miR-1, miR-133a, and miR-206 for Limb-girdle muscular dystrophy, Facioscapulohumeral muscular dystrophy, and Becker muscular dystrophy.
Matsuzaka Y; Kishi S; Aoki Y; Komaki H; Oya Y; Takeda S; Hashido K
Environ Health Prev Med; 2014 Nov; 19(6):452-8. PubMed ID: 25150707
[TBL] [Abstract][Full Text] [Related]
15. Early onset as a marker for disease severity in facioscapulohumeral muscular dystrophy.
Goselink RJM; Mul K; van Kernebeek CR; Lemmers RJLF; van der Maarel SM; Schreuder THA; Erasmus CE; Padberg GW; Statland JM; Voermans NC; van Engelen BGM
Neurology; 2019 Jan; 92(4):e378-e385. PubMed ID: 30568007
[TBL] [Abstract][Full Text] [Related]
16. Whole-body magnetic resonance imaging evaluation of facioscapulohumeral muscular dystrophy.
Leung DG; Carrino JA; Wagner KR; Jacobs MA
Muscle Nerve; 2015 Oct; 52(4):512-20. PubMed ID: 25641525
[TBL] [Abstract][Full Text] [Related]
17. Electrical impedance myography in facioscapulohumeral muscular dystrophy: A 1-year follow-up study.
Mul K; Heatwole C; Eichinger K; Dilek N; Martens WB; Van Engelen BGM; Tawil R; Statland JM
Muscle Nerve; 2018 Aug; 58(2):213-218. PubMed ID: 29543984
[TBL] [Abstract][Full Text] [Related]
18. Retinal arterial but not venous tortuosity correlates with facioscapulohumeral muscular dystrophy severity.
Longmuir SQ; Mathews KD; Longmuir RA; Joshi V; Olson RJ; Abràmoff MD
J AAPOS; 2010 Jun; 14(3):240-3. PubMed ID: 20603058
[TBL] [Abstract][Full Text] [Related]
19. The Facioscapulohumeral Muscular Dystrophy-Health Index: Development and evaluation of a disease-specific outcome measure.
Varma A; Weinstein J; Seabury J; Rosero S; Engebrecht C; Wagner E; Zizzi C; Luebbe EA; Dilek N; McDermott MP; Kissel J; Sansone V; Heatwole C
Muscle Nerve; 2023 Oct; 68(4):422-431. PubMed ID: 37610084
[TBL] [Abstract][Full Text] [Related]
20. Muscle fibrosis as a prognostic biomarker in facioscapulohumeral muscular dystrophy: a retrospective cohort study.
Ragozzino E; Bortolani S; Di Pietro L; Papait A; Parolini O; Monforte M; Tasca G; Ricci E
Acta Neuropathol Commun; 2023 Oct; 11(1):165. PubMed ID: 37849014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
